Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2026-03-06 @ 2:31 PM
Study NCT ID:
NCT01583218
Status:
COMPLETED
Last Update Posted:
2023-08-07
First Post:
2012-04-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Sponsor:
Portola Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
11-019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None